From May 19 to 23, 2025, a regional mission from the World Health Organization (WHO) is visiting our country to evaluate the vaccine safety monitoring system (the system for monitoring adverse events following immunization). The visit is aimed at strengthening the vaccine safety monitoring infrastructure and introducing WHO tools and resources in this area. Members of the mission have already begun holding meetings with representatives of the Ministry of Health and its relevant institutions.
As part of the visit, Larisa Kopp, Deputy Head of the Pharmacovigilance Department at the Paul Ehrlich Institute and a member of the mission, visited the Analytical Expertise Center (AEC). During her visit, the effectiveness of the pharmacovigilance system for medicines and vaccines in the country was assessed according to WHO standards, particularly using the WHO Global Benchmarking Tool (GBT).
During the meeting with the staff of AEC’s Pharmacovigilance Department, both parties discussed issues of mutual interest, as well as optimal solutions to challenges arising in the process.
